Webartikelen
- Aan COVID-19 gelieerde Kawasaki-achtige ziekte is geen Kawasaki
- Paediatric multisystem inflammatory syndrome From Wikipedia, the free encyclopedia
- Test confirms COVID-19 as trigger for rare Kawasaki-like syndrome in children
- Corona: Spätfolgen auch bei Kindern
- https://www.mayoclinic.org/diseases-conditions/mis-c-in-kids-covid-19/symptoms-causes/syc-20502550
- Covid-19-geassocieerde hyperinflammatie
Overzichtsartikelen MIS-C
A Systematic Review of Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 Infection
Nov 2020
Multisystem inflammatory syndrome in children: A systematic review
2020, sep 4
Post-infectious inflammatory disease in MIS-C features elevated cytotoxicity signatures and autoreactivity that correlates with severity
Nov 3, 2020
Wetenschappelijke artikelen A - Z
Association between a Novel Human Coronavirus* and Kawasaki Disease
Publication date 15 February 2005 | * HCoV-NH
- In conclusion, this case-control study suggests that there is an association between HCoV-NH infection and Kawasaki disease.
Nederlands
- Concluderend suggereert deze case-control studie dat er een verband bestaat tussen HCoV-NH-infectie en de ziekte van Kawasaki.
An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study
Publication date 14 May 2020
Childhood Multisystem Inflammatory Syndrome — A New Challenge in the Pandemic
Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2
COVID-19 and Kawasaki Disease: Finding the Signal in the Noise
Pre-publication Release 13 May 2020
Emergence of Kawasaki disease related to SARS-CoV-2 infection in an epicentre of the French COVID-19 epidemic: a time-series analysis
Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicentre observational study
July 10, 2020
Multisystem Inflammatory Syndrome in Children in New York State
June 30, 2020
Multisystem Inflammatory Syndrome in U.S. Children and Adolescents
Multisystem Inflammatory Syndrome Related to COVID-19 in Previously Healthy Children and Adolescents in New York City
Outbreak of Kawasaki disease in children during COVID-19 pandemic: a prospective observational study in Paris, France
Paediatric inflammatory multisystem syndrome and SARS-CoV-2 infectionin children
Publication date 15 May 2020
- Several countries affected by the coronavirus disease (COVID-19) pandemic recently reported cases of children that were hospitalised in intensive care due to a rare paediatric inflammatory multisystem syndrome (PIMS). The presenting signs and symptoms are a mix of the ones for Kawasaki disease (KD) and toxic shock syndrome (TSS) and are characterised, among others, by fever, abdominal pain and cardiac involvement. A possible temporal association with SARS-COV-2 infection has been hypothesised because some of the children that were tested for SARS-CoV-2 infection were either positive by polymerase chain reaction (PCR) or serology.
- Risk communication is needed to raise awareness in the medical community about PIMS-TS and inform parents and caregivers about signs and symptoms. The importance of timely contact with a healthcare worker should be stressed. Risk communication should emphasise that PIMS-TS is a rare condition and that its potential link with COVID-19 is neither established nor well understood.
Nederlands
- Verschillende landen die getroffen zijn door de pandemie van coronavirusziekte (COVID-19) hebben recentelijk gevallen gemeld van kinderen die op de intensive care werden opgenomen vanwege een zeldzaam pediatrisch inflammatoir multisysteem syndroom (PIMS). De aanwezige tekenen en symptomen zijn een combinatie van die voor de ziekte van Kawasaki (KD) en het toxisch-shocksyndroom (TSS) en worden onder andere gekenmerkt door koorts, buikpijn en cardiale betrokkenheid. Een mogelijke tijdelijke associatie met SARS-COV-2-infectie is verondersteld, omdat sommige kinderen die werden getest op SARS-CoV-2-infectie ofwel positief waren door polymerase kettingreactie (PCR) of serologie.
- Risicocommunicatie is nodig om de medische gemeenschap bewust te maken van PIMS-TS en ouders en verzorgers te informeren over tekenen en symptomen. Het belang van tijdig contact met een gezondheidswerker moet worden benadrukt. Risicocommunicatie moet benadrukken dat PIMS-TS een zeldzame aandoening is en dat de mogelijke link met COVID-19 niet is vastgesteld of niet goed wordt begrepen.
Post-infectious inflammatory disease in MIS-C features elevated cytotoxicity signatures and autoreactivity that correlates with severity
SARS-CoV-2–Related Inflammatory Multisystem Syndrome in ChildrenDifferent or Shared Etiology and Pathophysiology as Kawasaki Disease
SARS-CoV-2-related paediatric inflammatory multisystem syndrome, an epidemiological study, France, 1 March to 17 May 2020
Publication 4 june 2020
Nederlands